Engineered algae microrobots as photosynthetic living materials promote T cells’ anti-tumor immunity
Source abstract
Abstract
Dendritic cells (DCs) can form a T cell niche in tumor microenvironment and drive T cell proliferation through immunostimulatory ligands. However, hypoxia severely hinders the infiltration and proliferation of immune cells, thus restricting T cells' anti-tumor response. Microalgae have evolved an efficient photosynthesis system that might be a promising oxygen source to mitigate hypoxia. Here, we combine Chlorella vulgaris and a genetically engineered DC membrane, overexpressing immunostimulatory tumor necrosis factor (TNF) ligand proteins OX40L, 4-1BBL, and CD70, to assemble a "photosynthetic micron robot," which generates oxygen in situ to alleviate the state of hypoxia in the tumor microenvironment, thereby improving the efficiency of immunotherapy. TNF ligand proteins displayed on cell membrane nanovesicles and the photosynthetic micron robot bind to their cognate receptors on T cells and enhance the activity and proliferation of the effector T cells and memory T cells. Combined with programmed death-1 antibody, the photosynthetic micron robot prevents tumor relapse and metastasis in a mouse model.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Algal biology and biofuel production · Micro and Nano Robotics · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer Immunotherapy10.1126/scitranslmed.add2712 ↗
2. Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies10.1039/D3TB01358H ↗
3. Corticosteroids and Cancer Immunotherapy10.1158/1078-0432.CCR-22-3181 ↗
4. In vivo gene immunotherapy for cancer10.1126/scitranslmed.abo3603 ↗
5. Neutralization of NET-associated human ARG1 enhances cancer immunotherapy10.1126/scitranslmed.abq6221 ↗
6. Regulatory circuits of T cell function in cancer10.1038/nri.2016.80 ↗
7. Tissue-resident memory T cells at the center of immunity to solid tumors10.1038/s41590-018-0114-2 ↗
8. Regulation and Function of the PD-L1 Checkpoint10.1016/j.immuni.2018.03.014 ↗
9. Current status of interleukin-10 and regulatory T-cells in cancer10.1097/CCO.0000000000000006 ↗
10. Immune-based combination therapy to convert Immunologically cold tumors into hot tumors: an update and new insights10.1038/s41401-022-00953-z ↗
11. Signalling pathways of the TNF superfamily: a double-edged sword10.1038/nri1184 ↗
12. Fine-tuning of dendritic cell biology by the TNF superfamily10.1038/nri3193 ↗
13. Prospects for CD40-directed experimental therapy of human cancer10.1038/sj.cgt.7700527 ↗
14. The role of CD40 and CD154/CD40L in dendritic cells10.1016/j.smim.2009.05.010 ↗
15. OX40, OX40L and Autoimmunity: a Comprehensive Review10.1007/s12016-015-8498-3 ↗
16. Costimulation of T cells by OX40, 4-1BB, and CD2710.1016/S1359-6101(03)00025-X ↗
17. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion10.4049/jimmunol.165.6.3043 ↗
18. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion10.4049/jimmunol.164.1.107 ↗
19. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells10.1016/S1074-7613(01)00191-1 ↗
20. Immunotherapy of Cancer with 4-1BB10.1158/1535-7163.MCT-11-0677 ↗
21. CD70: An emerging target in cancer Immunotherapy10.1016/j.pharmthera.2015.07.007 ↗
22. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation10.4049/jimmunol.154.6.2612 ↗
23. CD27 and CD70 in T cell and B cell activation10.1016/j.coi.2005.04.004 ↗
24. Clinical targeting of the TNF and TNFR superfamilies10.1038/nrd3930 ↗
25. A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors10.1126/scitranslmed.abp9229 ↗
26. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells10.1038/s41586-019-1836-5 ↗
27. Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response10.1158/1078-0432.CCR-19-1321 ↗
28. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX4010.1038/nri1371 ↗
29. Role of 4-1BB: 4-1BB ligand in cancer Immunotherapy10.1038/sj.cgt.7700670 ↗
30. 4-1BB signaling beyond T cells10.1038/cmi.2010.82 ↗
31. Hypoxia-Driven Immune Escape in the Tumor Microenvironment10.3390/cells9040992 ↗
32. Exploiting tumour hypoxia in cancer treatment10.1038/nrc1367 ↗
33. Immunological mechanisms of the antitumor effects of supplemental oxygenation10.1126/scitranslmed.aaa1260 ↗
34. RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation10.1158/2326-6066.CIR-16-0129-T ↗
35. Inhibition of HIF-1 alpha by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma10.18632/oncotarget.2948 ↗
36. Mechanistic Justifications of Systemic Therapeutic Oxygenation of Tumors to Weaken the Hypoxia Inducible Factor 1 alpha-Mediated Immunosuppression10.1007/978-3-030-12734-3_8 ↗
37. Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors10.3858/emm.2009.41.12.103 ↗
38. An outlook on microalgal biofuels10.1126/science.1189003 ↗
39. Permeabilization of and extraction of lutein by distillable CO2-based alkyl carbamate ionic liquids10.1016/j.seppur.2020.117471 ↗
40. Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer10.1126/sciadv.aba5996 ↗
41. Surface-engineered chlorella alleviated hypoxic tumor microenvironment for enhanced chemotherapy and immunotherapy of first-line drugs10.1016/j.mattod.2022.06.024 ↗
42. Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia10.1038/s41563-022-01360-9 ↗
43. Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetes10.1126/sciadv.aba4311 ↗
44. Heterojunction engineered bioactive chlorella for cascade promoted cancer therapy10.1016/j.jconrel.2022.03.059 ↗
45. Cell-based intelligent micro/nanorobots for precise regulation and active biotherapy10.1016/j.matt.2023.09.013 ↗
46. Biohybrid Microalgae Robots: Design, Fabrication, Materials, and Applications
47. Applications of microalga-powered microrobots in targeted drug delivery10.1039/D3BM01095C ↗
48. Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics10.20517/evcna.2023.58 ↗
49. T cell exclusion, immune privilege, and the tumor microenvironment10.1126/science.aaa6204 ↗
50. Blue light is more essential than red light for maintaining the activities of photosystem II and I and photosynthetic electron transport capacity in cucumber leaves10.1016/S2095-3119(15)61202-3 ↗
51. The effect of supplementary light on the photosynthetic apparatus of strawberry plants under salinity and alkalinity stress10.1038/s41598-022-17377-8 ↗
52. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer10.1146/annurev-immunol-041015-055318 ↗
53. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review10.1002/jcp.27782 ↗
54. Memory T-Cell Heterogeneity and Terminology
55. Lymphocyte-mediated cytotoxicity10.1146/annurev.immunol.20.100201.131730 ↗
56. Perforin and granzymes: function, dysfunction and human pathology10.1038/nri3839 ↗
57. Metabolic Messengers: tumour necrosis factor10.1038/s42255-021-00470-z ↗
58. Effects of red and near-infrared LED light therapy on full-thickness skin graft in rats10.1007/s10103-019-02812-6 ↗
59. Red light-promoted skin barrier recovery: Spatiotemporal evaluation by transepidermal potential10.1371/journal.pone.0219198 ↗
60. Light emitting diode-red light for reduction of post-surgical scarring: Results from a dose-ranging, split-face, randomized controlled trial
61. Sex, but not skin tone affects penetration of red-light (660 nm) through sites susceptible to sports injury in lean live and cadaveric tissues
62. Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity